1. Home
  2. MRBK vs HUMA Comparison

MRBK vs HUMA Comparison

Compare MRBK & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meridian Corporation

MRBK

Meridian Corporation

HOLD

Current Price

$20.03

Market Cap

236.1M

Sector

Finance

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.56

Market Cap

191.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRBK
HUMA
Founded
2004
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
236.1M
191.4M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
MRBK
HUMA
Price
$20.03
$0.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$20.75
$6.19
AVG Volume (30 Days)
90.0K
6.7M
Earning Date
04-23-2026
05-15-2026
Dividend Yield
3.05%
N/A
EPS Growth
30.34
79.37
EPS
0.64
N/A
Revenue
$6,316,000.00
$2,038,000.00
Revenue This Year
$25.40
$444.16
Revenue Next Year
$8.15
$248.39
P/E Ratio
$31.38
N/A
Revenue Growth
10.13
N/A
52 Week Low
$13.81
$0.53
52 Week High
$21.59
$2.55

Technical Indicators

Market Signals
Indicator
MRBK
HUMA
Relative Strength Index (RSI) 54.10 35.56
Support Level $19.28 $0.55
Resistance Level $20.73 $0.75
Average True Range (ATR) 0.55 0.05
MACD 0.00 -0.00
Stochastic Oscillator 53.75 16.44

Price Performance

Historical Comparison
MRBK
HUMA

About MRBK Meridian Corporation

Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: